Table of Contents
Fetching ...

Normative Modeling for AD Diagnosis and Biomarker Identification

Songlin Zhao, Rong Zhou, Yu Zhang, Yong Chen, Lifang He

TL;DR

A novel normative modeling approach that incorporates focal loss and adversarial autoencoders (FAAE) for Alzheimer's Disease (AD) diagnosis and biomarker identification that significantly outperforms previous state-of-the-art methods.

Abstract

In this paper, we introduce a novel normative modeling approach that incorporates focal loss and adversarial autoencoders (FAAE) for Alzheimer's Disease (AD) diagnosis and biomarker identification. Our method is an end-to-end approach that embeds an adversarial focal loss discriminator within the autoencoder structure, specifically designed to effectively target and capture more complex and challenging cases. We first use the enhanced autoencoder to create a normative model based on data from healthy control (HC) individuals. We then apply this model to estimate total and regional neuroanatomical deviation in AD patients. Through extensive experiments on the OASIS-3 and ADNI datasets, our approach significantly outperforms previous state-of-the-art methods. This advancement not only streamlines the detection process but also provides a greater insight into the biomarker potential for AD. Our code can be found at \url{https://github.com/soz223/FAAE}.

Normative Modeling for AD Diagnosis and Biomarker Identification

TL;DR

A novel normative modeling approach that incorporates focal loss and adversarial autoencoders (FAAE) for Alzheimer's Disease (AD) diagnosis and biomarker identification that significantly outperforms previous state-of-the-art methods.

Abstract

In this paper, we introduce a novel normative modeling approach that incorporates focal loss and adversarial autoencoders (FAAE) for Alzheimer's Disease (AD) diagnosis and biomarker identification. Our method is an end-to-end approach that embeds an adversarial focal loss discriminator within the autoencoder structure, specifically designed to effectively target and capture more complex and challenging cases. We first use the enhanced autoencoder to create a normative model based on data from healthy control (HC) individuals. We then apply this model to estimate total and regional neuroanatomical deviation in AD patients. Through extensive experiments on the OASIS-3 and ADNI datasets, our approach significantly outperforms previous state-of-the-art methods. This advancement not only streamlines the detection process but also provides a greater insight into the biomarker potential for AD. Our code can be found at \url{https://github.com/soz223/FAAE}.

Paper Structure

This paper contains 8 sections, 6 equations, 3 figures, 2 tables.

Figures (3)

  • Figure 1: An overview of our proposed FAAE.
  • Figure 2: (a)-(b) Observed mean deviation and effect size of HC vs. AD on OASIS-3 for top-3 methods, respectively. (c) Parameter sensitivity on OASIS-3.
  • Figure 3: Comparative analysis of average regional-deviation values of AD across top-3 methods on OASIS-3 dataset.